An interventional study of posterior tibial nerve stimulation, PTNS in Stroke, Overactive Bladder (OAB) and Tibial Nerve, sponsored by Kutahya Health Sciences University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-07-31.
Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Treatment
This study is a prospective, randomized controlled clinical trial designed to evaluate the efficacy of transcutaneous electrical stimulation (posterior tibial nerve stimulation, PTNS) in the treatment of overactive bladder (OAB) developing after stroke.
Primary Hypothesis: PTNS therapy will significantly improve OAB symptoms in post-stroke patients compared to standard care/sham stimulation.
Primary Outcome Measure: Change from baseline in Overactive Bladder Symptom Score (OABSS) and/or frequency of urgency episodes as assessed after 12 weeks of treatment."
controlled clinical trial designed to evaluate the efficacy of transcutaneous electrical stimulation (posterior tibial nerve stimulation, PTNS) in the treatment of overactive bladder (OAB) developing after stroke.
8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.
This study's planned enrollment of 50 is close to the median of 49 across 6,024 interventional studies indexed under Stroke.
Browse Stroke studies →Kutahya Health Sciences University is the lead sponsor of 219 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
50 patient who assessed after 12 weeks of treatment
Device: posterior tibial nerve stimulation, PTNS
standart treatment group, wil folllow 12 months
posterior tibial nerve stimulation, PTNS
Change in daily frequency of urgency episodes
Number of urgency episodes per 24 hours recorded in patient bladder diary.
Time frame: Baseline and at 12 weeks.
Change in micturition frequency
Average number of micturitions per 24 hours.
Time frame: Baseline and at 12 weeks.
Plan to share: Yes — De-identified individual participant data (IPD) underlying the results (including demographic data, primary and secondary outcome measures) may be shared with qualified researchers upon reasonable request. Data will be available after publication of the study results for a period of 5 years. Access will be granted following approval of a data sharing agreement.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: De-identified individual participant data (IPD), along with the study protocol, SAP, and informed consent form, will be available upon reasonable request to the corresponding investigator. Data will be shared starting 6 months after publication of the study results and will be available for up to 5 years
Access criteria: De-identified individual participant data (IPD), including baseline demographics, primary and secondary outcome measures, and supporting documents (protocol, SAP, ICF), will be available to qualified researchers conducting scientific research in related fields. Data will be shared upon reasonable request to the corresponding investigator and access will be granted following approval of a data sharing agreement to ensure confidentiality and ethical use. For additional information, please contact: halib_ive@hotmail.com
Data sharing details ↗ · ksbu.edu.tr
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.
Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 12 months is below that.
Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kutahya Health Sciences University →